Cognitive-behavior therapy as a preventive adjunct to usual care for patients at ultra-high risk (UH...

Adolescents who regularly use marijuana may be more likely to experience subclinical paranoia and ha...

APA this week released the Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psy...

The Food and Drug Administration (FDA) on Friday approved Nuplazid (pimavanserin) tablets, the first...

According to a study in Schizophrenia Bulletin, approximately 1 in 13 people worldwide will have at ...

While previous studies suggest that psychotic experiences are associated with an elevated risk of su...